The Dutch National Growth Fund will invest 124.5 million euros in a new centre for animal-free biomedical testing. Of this investment, 55 million euros are awarded directly and 69.5 million euros are granted subject to conditions. Known as the Centre for Animal-Free Biomedical Translation, its aim is to generate safer, more effective treatments, while reducing animal suffering.
The Centre for Animal-Free Biomedical Translation (CPBT) will use this funding from the National Growth Funds (NGF) to accelerate the transition to animal-free biomedical innovations. This will offer economic and social benefits with improved medicines and less animal testing.